Renjith Ramachandran

Renjith Ramachandran

M D Anderson Cancer Center University of Texas - Houston / United States
Others
AD Scientific Index ID: 1419287
MD Anderson Cancer Center
person_outline Renjith Ramachandran's MOST POPULAR ARTICLES
1-) Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patientsLG Radvanyi, C Bernatchez, M Zhang, PS Fox, P Miller, J Chacon, R Wu, ...Clinical Cancer Research 18 (24), 6758-6770, 20124252012
2-) Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcomeMA Forget, C Haymaker, KR Hess, YJ Meng, C Creasy, T Karpinets, ...Clinical Cancer Research 24 (18), 4416-4428, 20181082018
3-) A novel method to generate and expand clinical-grade, genetically modified, tumor-infiltrating lymphocytesMA Forget, RJ Tavera, C Haymaker, R Ramachandran, S Malu, M Zhang, ...Frontiers in immunology 8, 908, 2017522017
4-) Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: a pilot studyY Qin, M Petaccia de Macedo, A Reuben, MA Forget, C Haymaker, ...Oncoimmunology 6 (6), e1321187, 2017502017
5-) Utilizing T-cell activation signals 1, 2, and 3 for tumor-infiltrating lymphocytes (TIL) expansion: the advantage over the sole use of interleukin-2 in cutaneous and uveal melanomaRJ Tavera, MA Forget, YU Kim, D Sakellariou-Thompson, CA Creasy, ...Journal of Immunotherapy 41 (9), 399-405, 2018402018